Park, H., Uhlemann, A. C., Jacobs, S. S., Mowbray, C., Jubelirer, T., Kelly, K. M., Walters, M., & Ladas, E. J. (2023). Title: Obesogenic microbial signatures and the development of obesity in childhood acute lymphoblastic leukemia. Leukemia Research, 126, 107017. https://doi.org/10.1016/j.leukres.2023.107017

Rippel, N., Tremblay, D., Zubizarreta, N., Podoltsev, N., Gotlib, J., Heaney, M., Kuykendall, A., O’Connell, C., Shammo, J. M., Fleischman, A., Kremyanskaya, M., Hoffman, R., Mesa, R., Yacoub, A., & Mascarenhas, J. (2022). Anagrelide for platelet-directed cytoreduction in polycythemia vera: Insights into utility and safety outcomes from a large multi-center database. Leukemia Research, 119, 106903. https://doi.org/10.1016/j.leukres.2022.106903

Tremblay, D., Ronner, L., Podoltsev, N., Gotlib, J., Heaney, M., Kuykendall, A., O’Connell, C., Shammo, J. M., Fleischman, A., Mesa, R., Yacoub, A., Hoffman, R., Moshier, E., Zubizarreta, N., & Mascarenhas, J. (2021). Ruxolitinib discontinuation in polycythemia vera: Patient characteristics, outcomes, and salvage strategies from a large multi-institutional database. Leukemia Research, 109, 106629. https://doi.org/10.1016/j.leukres.2021.106629